European Archives - Page 750 of 1303 - European Medical Journal

Reimagining patient care and future direction in Axial Spondyloarthritis and Psoriatic Arthritis

In this session chaired by Prof. Baraliakos, Prof. Nash and Prof. Machado discuss advances in artificial intelligence and machine learning that could potentially aid in the diagnosis and management of axSpA and PsA.

Reimagining the standard of care in Psoriatic Arthritis and Axial Spondyloarthritis

In this short summary video, Prof. Gottlieb discusses the role dermatologists can play in detecting PsA as well as the diagnostic tools that can be used to help achieve an early diagnosis.

Meet the expert: Managing Axial Psoriatic Arthritis

In this short summary video, Prof. Mease discusses the need for consensus on the definition and classification criteria for the axial manifestation of PsA, also highlighting the need for specific clinical assessments and clinical trials designed to investigate the efficacy of therapy options in this patient population.

LEO Pharma’s Monica Shaw on access to medicine challenges

Monica Shaw, Executive Vice President, Region EUROPE Plus, LEO Pharma, speaks with GOLD about digital transformation in healthcare

A New Prognosis for Multiple Sclerosis

We explore Professor Leigh Charvet’s vast research within multiple sclerosis, consider her time working in industry compared with her experiences in…

EMJ Podcast: Spotlight on Non-Small Cell Lung Cancer (NSCLC)

In this episode, Dr Marina Garassino explores the unmet needs for patients living with EGFR-mutated non-small cell lung cancer (NSCLC).

Medac Feature Image

Medac Satellite Symposium Eular 2021: MTX in RA therapy

Methotrexate has been established beyond doubt as the primary disease-modifying drug for the therapy of rheumatoid arthritis.

EMJ Podcast: Latest Developments in RET-driven Thyroid Cancer

Hear from two experts, as they discuss the latest efficacy and safety data in patients with RET-driven thyroid cancer, RET testing, and the future of RET-driven diseases.

Clarity on Cannabinoid-Based Products in Medicine

EMJ Neurology 9 [Supplement 1] 2021

This novel, extensive publication by scientific experts describes the present situation regarding medicinal use…

Talking to Vanessa Pott

Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, discusses patient advocacy and supporting carers.